Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
NASDAQ:IRTC
Holding IRTC?
Track your performance easily
IRTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$55.92 - $124.12
Previous Close$90.36
Volume270.26K
Average Volume (3M)539.53K
Market Cap
$2.83B
Enterprise Value$3.04B
Total Cash (Recent Filing)$522.03M
Total Debt (Recent Filing)$735.36M
Price to Earnings (P/E)―
Beta1.23
Next Earnings
Feb 20, 2025EPS Estimate
-$0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.85
Shares Outstanding31,298,034
10 Day Avg. Volume300,122
30 Day Avg. Volume539,527
Standard Deviation0.20
R-Squared0.11
Alpha0.00589
Financial Highlights & Ratios
Price to Book (P/B)39.46
Price to Sales (P/S)4.83
Price to Cash Flow (P/CF)27.80
P/FCF Ratio36.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.43
Enterprise Value/Gross Profit9.17
Enterprise Value/Ebitda-28.11
Forecast
1Y Price Target
$100.60Price Target Upside10.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Irhythm Technologies News
PremiumCompany Announcements
iRhythm Technologies Updates Equity Incentive Plan
Bulls Say, Bears Say
Bulls Say
Market LeadershipIRhythm is a pioneer of long-term continuous monitoring tests, delivering a 27% revenue CAGR over the past five years.
Product ExpansionThe expansion of Zio into asymptomatic populations is tracking beyond the team's initial expectations, with a recognized value proposition of preemptive detection.
Regulatory ProgressThe FDA has cleared two outstanding 510(k)s, paving the way for Zio MCT's future filing and clearance.
Bears Say
FDA Remediation ExpensesHigher FDA remediation expenses to address added 483 letters could challenge revenue and adjusted EBITDA.
Regulatory IssuesThe stock upside will be limited until there is greater certainty on resolving outstanding regulatory issues.
Revenue And Sales ExpectationsThe price target is lowered to $96 due to a lower 2025 sales estimate and slightly lower peer multiples.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
IRTC FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest stock price was $55.92 and its highest was $124.11 in the past 12 months.
What is Irhythm Technologies’s market cap?
Currently, no data Available
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is Feb 20, 2025 which is in 64 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Oct 30, 2024. The company reported -$1.48 earnings per share for the quarter, missing the consensus estimate of -$0.795 by -$0.685.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is -$0.33.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 31,298,035 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$1.48 in its last earnings report, missing expectations of -$0.795. Following the earnings report the stock price went down -4.395%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Among the largest hedge funds holding Irhythm Technologies’s share is Sands Capital Management LLC. It holds Irhythm Technologies’s shares valued at 158M.
---
Irhythm Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$100.60 (10.01% Upside)
$100.60 (10.01% Upside)
Blogger Sentiment
Bullish
IRTC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 4.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $963.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 3.9%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.54%
12-Months-Change
Fundamentals
Return on Equity
-103.34%
Trailing 12-Months
Asset Growth
106.86%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies, Inc. is a commercial-stage digital healthcare company, which engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers ZIO which diagnose many arrhythmias, avoiding multiple indeterminate tests, allowing for appropriate medical intervention, and prevents serious downstream medical events. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
---
IRTC Company Deck
---
IRTC Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth, successful international expansion, and important regulatory progress. However, these positives were balanced by significant regulatory challenges, increased operating expenses, and a higher net loss, resulting in a mixed sentiment.Read More>---
IRTC Stock 12 Month Forecast
Average Price Target
$100.60
▲(10.01% Upside)
Technical Analysis
Best Analysts Covering IRTC
1 Year
1 Year Success Rate
7/21 ratings generated profit
1 Year Average Return
-14.91%
reiterated a buy rating 4 months ago
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -14.91% per trade.
---